| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.31B | — | +45.8% |
| R&D Expense | $45.0M | — | +4.7% |
| SG&A Expense | $79.0M | — | -28.2% |
| Pre-tax Income | $4.58B | — | +85.5% |
| Income Tax | $1.40B | — | +117.0% |
| Net Income | $3.26B | — | +72.5% |
| EPS (Basic) | $3.01 | — | +79.2% |
| EPS (Diluted) | $3.00 | — | +78.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.78B | +14.8% | +86.8% |
| Short-term Investments | $4.0M | -99.3% | -77.8% |
| Accounts Receivable | $1.14B | +6.6% | +28.2% |
| Current Assets | $13.51B | +3.4% | +25.8% |
| Total Assets | $57.67B | +1.0% | +3.9% |
| Current Liabilities | $5.53B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.79B | — | +86.4% |
| Investing Cash Flow | -$302.0M | — | -140.9% |
| Financing Cash Flow | -$2.36B | — | -41.8% |
| +1.9% |
| Long-term Debt | $5.08B | -0.7% | -32.3% |
| Total Liabilities | $22.57B | -2.2% | -6.3% |
| Stockholders' Equity | $34.93B | +3.1% | +11.8% |